Virtual Reality During Exercise Testing
Effects of Virtual Reality on Cardiorespiratory Fitness Test Results
1 other identifier
interventional
24
1 country
1
Brief Summary
The goal of this clinical trial is to explore the effects of virtual reality use on maximal aerobic exercise test performance (aerobic capacity) in healthy adults. The main questions it aims to answer are:
- Does using a virtual reality program during a maximal aerobic exercise test lead to differences in VO2peak (maximal aerobic capacity)? and,
- Does using a virtual reality program during a maximal aerobic exercise test lead to differences in work rate at the ventilatory threshold? Participants will complete a maximal aerobic exercise test two times (separated by 1 week of recovery) under the following conditions:
- normal testing conditions in a lab
- while viewing a virtual reality video Researchers will compare the test results of both conditions to see if the use of a virtual reality program alters VO2peak or the ventilatory threshold.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 7, 2024
CompletedFirst Submitted
Initial submission to the registry
June 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 7, 2024
CompletedJune 21, 2024
June 1, 2024
4 months
June 13, 2024
June 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
VO2peak
The highest level of oxygen uptake averaged over a 20-second period.
Assessed during the exercise test for each condition.
Ventilatory threshold
The work load (in Watts) during the maximal cardiorespiratory exercise test at which breakpoints are identified between metabolic measures associated with the ventilatory threshold (CO2 production and O2 utilization; ventilatory equivalent for O2 and O2 utilization; and excess CO2 production).
Assessed during the exercise test for each condition.
Secondary Outcomes (9)
Peak power
Assessed during the exercise test for each condition.
Total test time
Assessed during the exercise test for each condition.
RPE
Assessed throughout the exercise test for each condition (at the end of the warm-up and end of every even-numbered stage)..
Affective Valence
Assessed throughout the exercise test for each condition (at the end of the warm-up and end of every even-numbered stage)..
%VO2peak at ventilatory threshold
Assessed during the exercise test for each condition.
- +4 more secondary outcomes
Study Arms (2)
Control condition completed first
EXPERIMENTALIn this arm, the Control condition (traditional maximal cardiorespiratory exercise test) will be completed first, and the Virtual Reality condition (traditional maximal cardiorespiratory exercise test with the addition of virtual reality video) will be completed second.
Virtual Reality condition completed first
EXPERIMENTALIn this arm, the Virtual Reality condition (traditional maximal cardiorespiratory exercise test with the addition of virtual reality video) will be completed first, and the Control condition (traditional maximal cardiorespiratory exercise test) will be completed second.
Interventions
Participants will watch a video on a virtual reality headset during the completion of the maximal cardiorespiratory exercise test.
Participants will complete the maximal cardiorespiratory exercise test under control conditions without video, music, or other distractions.
Eligibility Criteria
You may not qualify if:
- Answering "YES" to one or more items on the Physical Activity Readiness Questionnaire (PAR-Q).
- Women who are pregnant at the time of participation according to a pregnancy test.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Augusta University
Augusta, Georgia, 30909, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew R Moore, PhD
Augusta University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- It is not possible to mask the participant or data collection personnel from the conditions because the Virtual Reality condition requires that the headset be worn. Metabolic data and resulting outcomes (i.e. VO2peak value) will be analyzed by independent research assistants who will be blinded to the condition under which the data were gathered.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 13, 2024
First Posted
June 18, 2024
Study Start
June 7, 2024
Primary Completion
October 7, 2024
Study Completion
October 7, 2024
Last Updated
June 21, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share